Read More Pharma Industry News AdvanCell strengthens cancer drug pipeline with $112m Series C funding AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapy, has successfully completed an oversubscribed $112 million Series… byPallavi MadhirajuFebruary 4, 2025